US Expansion Radiopharmacy network growth in the US and recent Cyclone KIUBE deployments position IBA to win additional orders for cyclotrons and production solutions, with follow-on installation, maintenance, and service contracts at RLS Radiopharmacies sites.

Sterilization Growth Jabil’s Be-Wide X-ray sterilization project in Mississippi signals robust demand for industrial irradiation capacity, presenting cross-sell opportunities for turnkey sterilization solutions, equipment upgrades, and ongoing service across manufacturing sites.

Proton Leadership IBA’s leading role in proton therapy and radiopharmaceutical production opens avenues to partner with hospitals, clinics, and pharma manufacturers for on-site installations, dosimetry services, and maintenance programs leveraging the existing global installed base.

Growth Partnerships Board and leadership strengthening with a Chief Ventures & Corporate Officer indicates a bias toward external alliances, co-development, and venture opportunities—ideal for pursuing joint ventures, research collaborations, and strategic financing.

Sustainability Edge B Corp certification and verified sustainability performance can be leveraged to win ESG-focused procurement opportunities, attract responsible financing, and strengthen tender competitiveness.